Johnson Matthey PLC (LON:JMAT - Get Free Report) shot up 29.4% during trading on Thursday . The stock traded as high as GBX 1,888 ($25.62) and last traded at GBX 1,797 ($24.38). 4,429,253 shares were traded during trading, an increase of 61% from the average session volume of 2,754,108 shares. The stock had previously closed at GBX 1,389 ($18.85).
Johnson Matthey Stock Down 1.5%
The stock has a 50-day moving average of GBX 1,313.40 and a two-hundred day moving average of GBX 1,377.22. The company has a market cap of £2.85 billion, a P/E ratio of 28.96, a P/E/G ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings data on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. On average, research analysts anticipate that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Increases Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, April 16th. Investors of record on Thursday, April 10th were given a dividend of GBX 32 ($0.43) per share. The ex-dividend date of this dividend was Thursday, April 10th. This is a boost from Johnson Matthey's previous dividend of $22.00. This represents a dividend yield of 1.88%. Johnson Matthey's dividend payout ratio (DPR) is 130.84%.
Insider Activity at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon bought 30 shares of the firm's stock in a transaction that occurred on Wednesday, April 16th. The shares were bought at an average price of GBX 1,200 ($16.28) per share, with a total value of £360 ($488.47). Insiders have acquired 75 shares of company stock valued at $99,927 over the last ninety days. Insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Read More
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
